Product Program year 2025 Source: CMS Open Payments

CroFab

Biological Antidotes

NDC 50633-110-12

Open in the dashboard

General payments

$99,553

164 payments

Research payments

$0

0 payments

Through program year 2025, $99,553 in general payments and $0 in research payments were reported against CroFab (Antidotes).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $99,553 164

Breakdown

Who paid General payments · program year 2025
  1. BTG International, Inc. $99,553 164 payments
Top recipients General payments · program year 2025
  1. Denver Health Medical Center Teaching hospital · CO $40,627 41% · 9 payments
  2. Spencer Greene Medical Toxicology · Kingwood, TX $18,593 19% · 46 payments
  3. Lindsey Epperson Emergency Medicine · Oklahoma City, OK $10,052 10% · 25 payments
  4. Emory University Hospital Teaching hospital · GA $8,000 8% · 2 payments
  5. Andrew Monte Medical Toxicology · Aurora, CO $4,050 4% · 1 payment

The top 5 of 82 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Medical Toxicology Emergency Medicine $24,218 58% · 3 practitioners
  2. Emergency Medicine $14,036 34% · 30 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $758 2% · 8 practitioners
  4. Nurse Practitioner $328 <1% · 4 practitioners
  5. Nurse Practitioner, Acute Care Nurse Practitioner $251 <1% · 3 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Colorado $46,177 46% · 3 recipients
  2. Texas $23,765 24% · 29 recipients
  3. Oklahoma $12,550 13% · 28 recipients
  4. Georgia $8,150 8% · 3 recipients
  5. Louisiana $3,750 4% · 2 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

164 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record